Medigen Vaccine Biologics Corp. (6547) Stock Price & Analysis
6547 Stock Chart & Stats
- Day’s Range
- TWD 44.25 - TWD 47.35
- 52-Week Range
- TWD 35.15 - TWD 72.20
- Previous Close
- TWD 47.55
- Volume
- N/A
- Average Volume (3M)
- 2.27M
- Market Cap
- TWD 15.43B
- Enterprise Value
- TWD 14.01B
- Total Cash (Recent Filing)
- TWD 2.04B
- Total Debt (Recent Filing)
- TWD 1.10B
- Price to Earnings (P/E)
- ―
- Beta
- 0.25
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
6547 FAQ
What was Medigen Vaccine Biologics Corp.’s price range in the past 12 months?
What is Medigen Vaccine Biologics Corp.’s market cap?
When is Medigen Vaccine Biologics Corp.’s upcoming earnings report date?
How were Medigen Vaccine Biologics Corp.’s earnings last quarter?
Is Medigen Vaccine Biologics Corp. overvalued?
Does Medigen Vaccine Biologics Corp. pay dividends?
What is Medigen Vaccine Biologics Corp.’s EPS estimate?
How many shares outstanding does Medigen Vaccine Biologics Corp. have?
What happened to Medigen Vaccine Biologics Corp.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Medigen Vaccine Biologics Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Medigen Vaccine Biologics Corp.
Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. It develops enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection with severe complications; and Quadrivalent influenza vaccine, which is in Phase III clinical trial for the treatment of influenza viruses. The company also develops dengue vaccines, which has completed Phase II clinical trial to treat dengue; anti respiratory syncytial virus (RSV), which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19. The company was incorporated in 2012 and is headquartered in Zhubei, Taiwan. Medigen Vaccine Biologics Corporation operates as a subsidiary of Medigen Biotechnology Corp.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Leo Lee
- Employees
- 1,226
- Website
- www.medigenvac.com
- Address
- No. 68, Shengyi 3rd Road, Zhubei, KH, 30261, TW
Medigen Vaccine Biologics Corp. (6547) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |

